Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
RTNominal down34.050 -1.800 (-5.021%)

13/09/2021 10:59

MicroPort (00853) unit to buy 45% of Kerui Pharmaceutical

[ET Net News Agency, 13 September 2021] MicroPort Scientific Corporation (00853) said
Shanghai MicroPort Medical (Group) Co., Ltd. (Shanghai MicroPort), a subsidiary of the
company, has entered into an equity transfer agreement with Fujian 618 Industrial Equity
Investment Partnership (Limited Partnership)) and Fujian Tendering and Procurement Group
Co., Ltd. (together, the vendors), under which Shanghai MicroPort as the strategic
investor, will acquire from the vendors 45% of the equity interests in Fujian Kerui
Pharmaceutical Co., Ltd. (Kerui Pharmaceutical) at the consideration of approximately
RMB111 million.
Upon completion of the transaction, Shanghai MicroPort will become the single largest
shareholder of Kerui Pharmaceutical. Shanghai MicroPort will also, through contractual
arrangement, obtain the control of the daily operation of Kerui Pharmaceutical.
Kerui Pharmaceutical is a national high-tech enterprise engaged in the research and
development, production and sales of high-value-added fermentation-based active
pharmaceutical ingredients (APIs) such as immunosuppressants and anti-tumour agents. (RC)

Remark: Real time quote last updated: 26/11/2021 17:59
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2021 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.